Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
3.480
+0.235 (7.24%)
Mar 17, 2025, 1:22 PM EDT - Market open
Nanobiotix Employees
Nanobiotix had 102 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
102
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$443,335
Profits / Employee
-$351,620
Market Cap
152.03M
Employees Chart
NBTX News
- 6 weeks ago - Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025 - GlobeNewsWire
- 7 weeks ago - NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer - GlobeNewsWire
- 3 months ago - NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024 - GlobeNewsWire
- 3 months ago - NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer - GlobeNewsWire
- 4 months ago - NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms - GlobeNewsWire
- 4 months ago - NANOBIOTIX to Participate in Multiple Investor Conferences in November - GlobeNewsWire
- 6 months ago - NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth - GlobeNewsWire